Like many people, Elizabeth Holmes was scared of needles. how its policy of policing internal dissent ended in tragedy.how Theranos used statistics to mislead regulators, investors and customers.why a company selling a device that didn’t work was valued at $9 billion.In this summary of Bad Blood by John Carreyrou, you’ll learn And that’s where this extraordinary tale of lies, subterfuge, deception and trickery starts getting really weird. A tiny, ultra-portable, cheap and quick blood-testing device capable of screening for 200 common conditions, it was hailed as a “miracle machine.” If something sounds too good to be true, it usually is. Either the company makes it big and changes the world forever – think Google, Apple and Amazon – or it falls on its sword after tasting defeat in a cutthroat market.īut sometimes things take a more bizarre turn.Įnter Elizabeth Holmes, the charismatic, turtleneck-wearing wunderkind whose promise of a medical revolution had investors lining up to fund her brainchild: Theranos. Things usually pan out one of two ways for these swaggering upstarts. This Californian Mecca of braggadocio runs on inflated claims, white lies and an ingrained culture of faking-it-till-you-make-it. Silicon Valley start-ups aren’t known for soft-pedaling their products’ virtues.
0 Comments
Leave a Reply. |